Walgreens Boots Alliance (NASDAQ:WBA) Sets New 1-Year Low at $17.49

Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Get Free Report) hit a new 52-week low on Friday . The stock traded as low as $17.49 and last traded at $17.91, with a volume of 1135772 shares changing hands. The stock had previously closed at $17.60.

Analysts Set New Price Targets

WBA has been the subject of a number of research analyst reports. Morgan Stanley lowered their price target on Walgreens Boots Alliance from $21.00 to $20.00 and set an "underweight" rating for the company in a report on Monday, April 1st. Raymond James reissued a "market perform" rating on shares of Walgreens Boots Alliance in a research note on Tuesday, March 26th. UBS Group dropped their price objective on Walgreens Boots Alliance from $25.00 to $22.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 3rd. Deutsche Bank Aktiengesellschaft dropped their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set a "hold" rating on the stock in a research note on Wednesday, April 3rd. Finally, Barclays initiated coverage on Walgreens Boots Alliance in a research note on Wednesday, January 3rd. They issued an "underweight" rating and a $21.00 price objective for the company. Four equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $24.36.

Walgreens Boots Alliance Stock Performance

The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. The business has a 50 day moving average price of $20.01 and a two-hundred day moving average price of $21.77. The company has a market cap of $15.27 billion, a P/E ratio of -2.53, a price-to-earnings-growth ratio of 1.10 and a beta of 0.73.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The company had revenue of $37.05 billion for the quarter, compared to the consensus estimate of $35.86 billion. During the same quarter in the previous year, the business earned $1.16 EPS. Walgreens Boots Alliance's revenue was up 6.3% compared to the same quarter last year. On average, sell-side analysts anticipate that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Insider Activity at Walgreens Boots Alliance

In other news, Director Valerie B. Jarrett bought 4,456 shares of Walgreens Boots Alliance stock in a transaction on Monday, January 29th. The shares were purchased at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the acquisition, the director now owns 4,456 shares of the company's stock, valued at $99,992.64. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, Director Valerie B. Jarrett bought 4,456 shares of Walgreens Boots Alliance stock in a transaction on Monday, January 29th. The shares were purchased at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the acquisition, the director now owns 4,456 shares of the company's stock, valued at $99,992.64. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Inderpal S. Bhandari bought 3,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, April 11th. The shares were purchased at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the acquisition, the director now directly owns 3,000 shares in the company, valued at approximately $54,150. The disclosure for this purchase can be found here. Insiders have acquired a total of 13,456 shares of company stock worth $270,423 in the last 90 days. Company insiders own 17.40% of the company's stock.

Hedge Funds Weigh In On Walgreens Boots Alliance

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Highlander Capital Management LLC bought a new position in shares of Walgreens Boots Alliance during the 4th quarter valued at $26,000. Pineridge Advisors LLC bought a new position in shares of Walgreens Boots Alliance during the 4th quarter valued at $26,000. Venturi Wealth Management LLC lifted its holdings in shares of Walgreens Boots Alliance by 1,241.8% during the 4th quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator's stock valued at $28,000 after buying an additional 981 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in shares of Walgreens Boots Alliance by 308.4% during the 3rd quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator's stock valued at $25,000 after buying an additional 845 shares during the period. Finally, Rocky Mountain Advisers LLC bought a new position in shares of Walgreens Boots Alliance during the 4th quarter valued at $30,000. 58.59% of the stock is owned by institutional investors.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.